Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Comparative Immunotoxicity Of Mesoporous Silica Nanoparticles And Colloidal Silica Nanoparticles In Mice

Soyoung Lee, M. Kim, D. Lee, T. Kwon, D. Khang, H. Yun, S. Kim
Published 2013 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Background Mesoporous silica (MPS) nanoparticles (NPs), which have a unique pore structure and extremely large surface area and pore volume, have received much attention because of their biomedical application potential. Using MPS NPs for biomedical devices requires the verification of their biocompatibility because the surface area of NPs is one of the most important determinants of toxicity, including the cellular uptake and immune response. We have previously reported that the cytotoxicity and inflammation potential of MPS NPs have been shown to be lower than those of general amorphous colloidal silica (Col) NPs in macrophages, but the low cytotoxicity does not guarantee high biocompatibility in vivo. In this study, we compared the in vivo immunotoxicity of MPS and Col NPs in the mouse model to define the effects of pore structural conditions of silica NPs. Materials and methods Both MPS and Col NPs (2, 20, and 50 mg/kg/day) were intraperitoneally administered in female BALB/c mice for 4 weeks, and clinical toxicity, lymphocyte population, serum IgG/IgM levels, and histological changes were examined. Results There was no overt sign of clinical toxicity in either MPS- or Col-treated mice. However, MPS NPs led to significant increases in liver and spleen weight and splenocyte proliferation. Mice treated with MPS NPs showed altered lymphocyte populations (CD3+, CD45+, CD4+, and CD8+) in the spleen, increased serum IgG and IgM levels, and histological changes. Despite slight changes in lymphocyte populations in the spleen, Col NPs did not alter other immunological factors. Conclusion The results indicate that in vivo exposure to MPS NPs caused more damage to systemic immunity than that of Col NPs through the dysregulation of the spleen. The results for in vivo data are inconsistent with those for in vitro data, which show lower cytotoxicity for MPS NPs. These results suggest the importance of verifying biocompatibility both in vitro and in vivo during the design of new nanomaterials.
This paper references
10.1016/S1359-6446(05)03575-0
PEGylation, successful approach to drug delivery.
F. Veronese (2005)
10.1016/j.tiv.2010.01.001
Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line.
Y. Ye (2010)
10.1039/B702103H
Design and preparation of bioactive glasses with hierarchical pore networks.
H. Yun (2007)
[Structure and function of immunoglobulins].
F. Seiler (1982)
10.1016/j.ejpb.2009.02.005
Silica nanoparticles as hepatotoxicants.
H. Nishimori (2009)
10.1007/s00204-003-0497-0
Oral exposure to inorganic mercury alters T lymphocyte phenotypes and cytokine expression in BALB/c mice
S. Kim (2003)
10.1016/j.actbio.2011.02.014
Effect of the pore structure of bioactive glass balls on biocompatibility in vitro and in vivo.
H. Yun (2011)
Nanotoxicology and
I Linkov
10.1016/J.TRSL.2007.09.001
Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
S. Roth (2008)
10.1002/jbm.a.34024
The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles.
Xuezi Sang (2012)
10.1198/tech.2002.s729
Making Hard Decisions
R. Clemen (2002)
10.1088/0957-4484/22/5/055101
Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice.
X. Lu (2011)
10.1016/j.taap.2008.04.009
Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells.
D. Huang (2008)
10.1021/JP207713X
Effect of Hydrophilic and Hydrophobic Nanoparticles on the Surface Pressure Response of DPPC Monolayers
E. Guzmán (2011)
10.3109/08923970903305499
Toxic effects of mercuric sulfide on immune organs in mice
Hee-young Son (2010)
10.1038/sj.gt.3302937
Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen
K. Tan (2007)
10.1021/nn103077k
Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Yannan Zhao (2011)
Hepatotoxicity of silica nanoparticles with a diameter of 100 nm.
T. Hasezaki (2011)
10.1016/j.addr.2008.03.012
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
I. Slowing (2008)
10.1039/C2SM07097A
Influence of silica nanoparticles on dilational rheology of DPPC–palmitic acid Langmuir monolayers
E. Guzmán (2012)
10.1038/sj.gt.3301914
Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation
E. Tupin (2003)
10.1016/j.biomaterials.2008.07.007
The biocompatibility of mesoporous silicates.
S. Hudson (2008)
10.1016/j.biomaterials.2011.12.008
Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles.
Tianlong Liu (2012)
10.1093/TOXSCI/KFM240
Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
R. Murdock (2008)
10.1016/J.NANO.2005.10.003
Nanomedicine and nanotoxicology: two sides of the same coin.
V. Kagan (2005)
10.1016/j.taap.2009.06.011
Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells.
Erika Witasp (2009)
10.1016/j.biomaterials.2010.10.035
Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice.
Tianlong Liu (2011)
10.1016/j.biomaterials.2011.08.042
The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis.
S. Lee (2011)
10.1038/nri1669
Structure and function of the spleen
R. Mebius (2005)
Powered by TCPDF (www.tcpdf.org)
(2013)
10.1016/j.ejpb.2009.03.007
Histological analysis of 70-nm silica particles-induced chronic toxicity in mice.
H. Nishimori (2009)
Effect of 70-nm silica particles on the toxicity of acetaminophen, tetracycline, trazodone, and 5-aminosalicylic acid in mice.
X. Li (2011)
10.1016/j.toxlet.2009.04.017
The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Minjung Cho (2009)
10.1016/J.TAAP.2006.10.004
In vitro toxicity of silica nanoparticles in human lung cancer cells.
W. Lin (2006)
10.1093/TOXSCI/59.1.108
Immunoglobulin responses to experimental silicosis.
S. H. Huang (2001)
Comparative immunotoxicity of silica NPs in vivo International Journal of Nanomedicine
(2013)
10.1016/j.jaci.2009.09.046
Structure and function of immunoglobulins.
H. Schroeder (2010)
10.2147/IJN.S
Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes
M. Bottini (2007)
10.1002/tox.20459
Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice
Hee-young Son (2009)
10.1111/j.1365-2796.2009.02187.x
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
G. Oberdörster (2010)
10.1038/nrc1782
Paradoxical roles of the immune system during cancer development
K. E. D. Visser (2006)
10.1021/NL0714785
Mesoporous silica particles induce size dependent effects on human dendritic cells.
H. Vallhov (2007)
10.1016/j.toxlet.2008.10.012
Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro.
E. Park (2009)
10.1016/J.COPBIO.2007.11.008
Nanotoxicity: the growing need for in vivo study.
H. C. Fischer (2007)
Comparative immunotoxicity of silica NPs in vivo International Journal of Nanomedicine downloaded from
and nanotoxicology : two sides of the same coin
VE Kagan (2005)
10.1021/NL0710710
Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles.
C. Sayes (2007)
10.1016/j.nano.2008.01.001
Nanotoxicology and nanomedicine: making hard decisions.
I. Linkov (2008)



This paper is referenced by
10.2217/nnm-2018-0076
The toxicity of silica nanoparticles to the immune system.
L. Chen (2018)
CIA_A_237601 97..110
X. Li (2020)
10.1002/wnan.1415
Toward RNA nanoparticle vaccines: synergizing RNA and inorganic nanoparticles to achieve immunopotentiation.
R. K. Delong (2017)
10.3390/pharmaceutics10030118
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Reema Narayan (2018)
10.1007/s40195-019-00926-y
Inducing Macrophages M2 Polarization by Dexamethasone Laden Mesoporous Silica Nanoparticles from Titanium Implant Surface for Enhanced Osteogenesis
J. Luo (2019)
10.1007/978-981-15-4735-5
Allergy and Immunotoxicology in Occupational Health - The Next Step
T. Otsuki (2020)
10.2147/IJN.S132780
High drug-loading nanomedicines: progress, current status, and prospects
Shihong Shen (2017)
10.1016/j.tox.2014.11.005
Carbon black nanoparticle exposure during middle and late fetal development induces immune activation in male offspring mice.
Y. El-Sayed (2015)
In vitro toxicological assessment of amorphous silica particles in relation to their characteristics and mode of action in human skin cells
Claudia Moia (2015)
10.2147/IJN.S57934
Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge
J. Kim (2014)
10.3390/ijms15046961
Systemic Immune Effects of Titanium Dioxide Nanoparticles after Repeated Intratracheal Instillation in Rat
Y. Fu (2014)
10.1002/9781118845530.CH30
Environmental Risks of Nanotechnology
M. Méndez-Rojas (2014)
10.1016/j.jconrel.2019.04.041
Subchronic toxicity of silica nanoparticles as a function of size and porosity.
R. Mohammadpour (2019)
10.21668/HEALTH.RISK/2016.4.10.ENG
Impact of silica dioxide nanoparticles on the morphology of internal organs in rats by oral supplementation
N. Zaitseva (2016)
10.1016/j.cbi.2018.07.013
Global metabolomics approach in in vitro and in vivo models reveals hepatic glutathione depletion induced by amorphous silica nanoparticles.
Nivedita Chatterjee (2018)
10.1007/s12011-020-02386-3
Toxic Impacts of Amorphous Silica Nanoparticles on Liver and Kidney of Male Adult Rats: an In Vivo Study.
Rehab A Azouz (2020)
10.1016/j.cis.2016.04.001
Template-based syntheses for shape controlled nanostructures.
M. Pérez-Page (2016)
10.1021/acs.chemrev.5b00321
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.
Alyssa B. Chinen (2015)
10.1088/1757-899X/98/1/012009
Nanomaterials in consumer's goods: the problems of risk assessment
I. V. Gmoshinski (2015)
10.1080/02772248.2018.1485921
The Toxicology of Silica Nanoparticles: A Review
P. Mohammadi (2018)
10.1155/2016/2959414
Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets
V. Gryshchuk (2016)
10.1002/wnan.1658
Understanding the mechanisms of silica nanoparticles for nanomedicine
Z. Li (2020)
10.1515/ntrev-2015-0057
Smart mesoporous silica nanoparticles for controlled-release drug delivery
Mahdi Karimi (2016)
10.1016/j.tiv.2018.06.019
Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles.
Katharina Braun (2018)
10.1080/17435390.2020.1842932
Pulmonary toxicity of synthetic amorphous silica - effects of porosity and copper oxide doping.
Niels Hadrup (2020)
10.17533/UDEA.IATREIA.V29N4A06
Efecto inmunomodulador de nanopartículas usadas en nanomedicina
Diana Maryory Gómez-Gallego (2016)
10.1039/c4nr04864d
Mesoporous titania based yolk-shell nanoparticles as multifunctional theranostic platforms for SERS imaging and chemo-photothermal treatment.
W. Zhang (2014)
10.2147/IJN.S208496
Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels
Liqun Jiang (2019)
10.1038/s41578-020-0230-0
Synthetic amorphous silica nanoparticles: toxicity, biomedical and environmental implications
Jonas G. Croissant (2020)
10.2147/IJN.S52239
Allergenicity and toxicology of inhaled silver nanoparticles in allergen-provocation mice models
Hsiao-Chi Chuang (2013)
10.1177/2041731413503357
Silica-based mesoporous nanoparticles for controlled drug delivery
Sooyeon Kwon (2013)
10.1016/J.CCR.2016.04.019
The application of mesoporous silica nanoparticle family in cancer theranostics
Yin Feng (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar